HK1202155A1 - 用於初次慢性腎臟疾病的發展的預後生物標誌物 - Google Patents

用於初次慢性腎臟疾病的發展的預後生物標誌物

Info

Publication number
HK1202155A1
HK1202155A1 HK15102572.5A HK15102572A HK1202155A1 HK 1202155 A1 HK1202155 A1 HK 1202155A1 HK 15102572 A HK15102572 A HK 15102572A HK 1202155 A1 HK1202155 A1 HK 1202155A1
Authority
HK
Hong Kong
Prior art keywords
progression
kidney disease
chronic kidney
prognostic biomarkers
primary chronic
Prior art date
Application number
HK15102572.5A
Other languages
English (en)
Inventor
Joachim Struck
Benjamin Dieplinger
Thomas Mueller
Barbara Kollerits
Florian Kronenberg
Original Assignee
Brahms Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brahms Gmbh filed Critical Brahms Gmbh
Publication of HK1202155A1 publication Critical patent/HK1202155A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
HK15102572.5A 2008-10-22 2015-03-13 用於初次慢性腎臟疾病的發展的預後生物標誌物 HK1202155A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20080167312 EP2180322A1 (en) 2008-10-22 2008-10-22 Prognostic biomarkers for the progression of primary chronic kidney disease

Publications (1)

Publication Number Publication Date
HK1202155A1 true HK1202155A1 (zh) 2015-09-18

Family

ID=40524763

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15102572.5A HK1202155A1 (zh) 2008-10-22 2015-03-13 用於初次慢性腎臟疾病的發展的預後生物標誌物

Country Status (8)

Country Link
US (1) US9128107B2 (zh)
EP (3) EP2180322A1 (zh)
JP (2) JP5553835B2 (zh)
CN (2) CN104374920B (zh)
DK (1) DK2356466T3 (zh)
ES (2) ES2587717T3 (zh)
HK (1) HK1202155A1 (zh)
WO (1) WO2010046137A1 (zh)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7867186B2 (en) 2002-04-08 2011-01-11 Glaukos Corporation Devices and methods for treatment of ocular disorders
DE10316583A1 (de) * 2003-04-10 2004-10-28 B.R.A.H.M.S Aktiengesellschaft Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung
CA3086149A1 (en) 2006-04-04 2007-10-11 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
US7838250B1 (en) 2006-04-04 2010-11-23 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
DE102006060112A1 (de) * 2006-12-20 2008-06-26 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM
SG10201704689XA (en) 2008-01-18 2017-07-28 Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
AU2010259022B2 (en) 2009-06-08 2016-05-12 Singulex, Inc. Highly sensitive biomarker panels
CA3067107C (en) 2010-06-03 2022-07-12 Idexx Laboratories, Inc. Markers for renal disease
JP5827323B2 (ja) * 2010-06-18 2015-12-02 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング ガン罹患の予測のためのバイオマーカー
AU2011280936A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
KR20130041961A (ko) 2010-07-23 2013-04-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 체액에서 질환 또는 상태의 특징을 검출하는 방법
TW201209171A (en) 2010-07-23 2012-03-01 Harvard College Methods of detecting diseases or conditions using phagocytic cells
US20130266940A1 (en) 2010-07-23 2013-10-10 President And Fellows Of Harvard College Methods of Detecting Kidney-Associated Diseases or Conditions
EP2596116A4 (en) 2010-07-23 2014-03-19 Harvard College METHODS FOR DETECTION OF AUTOIMMUNE OR IMMUNE-RELATED DISEASES / PATHOLOGIES
WO2013096740A1 (en) * 2011-12-21 2013-06-27 Alere San Diego Inc. Methods and compositions for assigning likelihood of chronic kidney disease progression
EP3385717A3 (en) 2013-03-09 2018-10-24 Harry Stylli Methods of detecting prostate cancer
EP2965077B1 (en) 2013-03-09 2022-07-13 Harry Stylli Methods of detecting cancer
GB201404789D0 (en) * 2014-03-18 2014-04-30 Univ Dundee Biomarkers
EP3191846A4 (en) 2014-09-11 2018-06-13 Harry Stylli Methods of detecting prostate cancer
JP6841765B2 (ja) * 2015-04-24 2021-03-10 シュピーンゴテック ゲゼルシャフト ミット ベシュレンクテル ハフツング 慢性腎疾患の発症のリスクを予測するための方法
US10531837B1 (en) 2015-09-25 2020-01-14 Cerner Innovation, Inc. Predicting chronic kidney disease progression
WO2017089474A1 (en) * 2015-11-27 2017-06-01 Brahms Gmbh MR-proADM AS MARKER FOR THE EXTRACELLULAR VOLUME STATUS OF A SUBJECT
US20180186543A1 (en) * 2016-12-29 2018-07-05 Dow Global Technologies Llc Packaging Article with Three-Dimensional Loop Material
CN107037172B (zh) * 2017-03-29 2018-03-06 山东大学 Cox4i1蛋白87位发生质量偏移的赖氨酸在制备重度少弱精诊断试剂中的用途
CN107085666B (zh) * 2017-05-24 2020-07-17 山东大学 疾病风险评估与个性化健康报告生成系统及方法
CN111065922A (zh) * 2017-09-13 2020-04-24 B.R.A.H.M.S有限公司 肾上腺髓质素原作为危重病患者的肾脏替代治疗的指标
CN112034189B (zh) * 2020-06-16 2023-03-17 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） 内皮素-1作为用于评价原发性慢性肾脏病患者无症状心血管器官损伤的标志物的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE52916C (de) * F. utsch in Köln-Deutz, Victoriastr. 44 Setzmaschine
DE69509626T2 (de) * 1994-12-09 2000-01-13 Shionogi & Co Sandwich-Immunotestverfahren für N-Peptide
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
GB2403533A (en) * 2003-06-30 2005-01-05 Orion Corp Atrial natriuretic peptide and brain natriuretic peptide and assays and uses thereof
EP1628136A1 (en) * 2004-08-19 2006-02-22 B.R.A.H.M.S. Aktiengesellschaft Method of diagnosis of disease using copeptin
WO2007062676A1 (en) * 2005-12-01 2007-06-07 B.R.A.H.M.S. Aktiengesellschaft Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
DE102006052916A1 (de) * 2006-11-08 2008-05-15 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung von Diabetes mellitus mittels MR-proADM

Also Published As

Publication number Publication date
EP2796879B1 (en) 2016-05-25
EP2356466A1 (en) 2011-08-17
CN104374920A (zh) 2015-02-25
JP2012506546A (ja) 2012-03-15
ES2618077T3 (es) 2017-06-20
JP2013178278A (ja) 2013-09-09
JP5553835B2 (ja) 2014-07-16
CN104374920B (zh) 2017-11-03
EP2356466B1 (en) 2016-12-21
CN102203621A (zh) 2011-09-28
US9128107B2 (en) 2015-09-08
DK2356466T3 (en) 2017-04-03
EP2796879A1 (en) 2014-10-29
US20120003752A1 (en) 2012-01-05
ES2587717T3 (es) 2016-10-26
WO2010046137A1 (en) 2010-04-29
EP2180322A1 (en) 2010-04-28
CN102203621B (zh) 2016-11-23
JP5718981B2 (ja) 2015-05-13

Similar Documents

Publication Publication Date Title
HK1202155A1 (zh) 用於初次慢性腎臟疾病的發展的預後生物標誌物
IL216720A (en) Biological markers for assessing kidney disease
GB0719792D0 (en) Cancer biomarkers
HK1154652A1 (en) Methods of prognosis in chronic kidney disease
EP2373999A4 (en) NEW BIOMARKERS
EP2021515A4 (en) METHYLATED PROMOTERS AS BIOMARKERS OF COLON CANCER
EP2158326A4 (en) BIOMARKERS FOR THE DIAGNOSIS OF AUTOIMMUNE DISEASES
EP2160478A4 (en) Prognostic Diagnosis of Kidney Diseases
EP2089722A4 (en) BIOMARKERS
BRPI1006075A2 (pt) biomarcadores de cancer
GB2474618B (en) Predictive biomarkers
ZA200907027B (en) Biomarkers for multiple sclerosis
EP2265642A4 (en) BIOMARKERS
IL206631A0 (en) Biomarkers for the prediction of renal injury
BRPI0920069A2 (pt) biomarcadores
HK1134690A1 (zh) 子宮內膜生物標誌物
EP2263086A4 (en) BIOMARKERS
GB0618127D0 (en) Biomarker
EP2207685A4 (en) DETERMINING THE CHARACTERISTICS OF A LIQUID
GB0818660D0 (en) Biomarkers
GB0807214D0 (en) Biomarkers
EP2210099A4 (en) BIOMARKER FOR OVARIAL CARCINOMA
EP2265641A4 (en) BIOMARKERS
GB0821912D0 (en) Biomarkers
GB0818658D0 (en) Biomarkers